felin
coronaviru
fcov
pathogen
caus
lethal
infecti
diseas
cat
felin
infecti
periton
two
serotyp
type
fcov
type
ii
fcov
accord
previou
studi
type
fcov
infect
inhibit
compound
induc
intracellular
cholesterol
accumul
wherea
type
ii
fcov
infect
inhibit
intracellular
cholesterol
accumul
report
disrupt
late
endosom
function
base
find
type
ii
fcov
consid
enter
cytosol
late
earli
endosom
respect
investig
whether
antivir
activ
late
endosom
traffick
inhibitor
cholesterolaccumul
agent
differ
fcov
serotyp
late
endosom
traffick
inhibitor
inhibit
type
ii
fcov
infect
inhibit
type
fcov
infect
type
fcov
infect
inhibit
cholesterolaccumul
triazol
noncholesterolaccumul
triazol
phenomena
observ
felin
cell
line
felin
primari
macrophag
studi
provid
addit
inform
differ
intracellular
reproduct
cycl
type
type
ii
fcov
felin
coronaviru
fcov
positivesens
rna
viru
speci
alphacoronaviru
genu
alphacoronaiviru
subfamili
coronavirina
famili
coronavirida
divid
two
serotyp
type
ii
base
amino
acid
sequenc
spike
protein
type
fcov
domin
serotyp
europ
asia
fcov
also
divid
two
biotyp
felin
infecti
periton
viru
fip
viru
fipv
virul
fcov
felin
enter
coronaviru
fecv
avirul
fcov
accord
pathogenesi
anim
fipv
infect
typic
caus
lethal
diseas
felida
known
fip
hallmark
patholog
find
fip
domest
cat
serou
fluid
periton
pleural
caviti
pyogranulomat
lesion
intern
organ
dissemin
fibrin
seros
organ
surfac
fipvinfect
cell
lesion
serou
effus
predominantli
consist
macrophag
fipvinfect
macrophag
suggest
exacerb
diseas
condit
fcov
attach
cell
surfac
felin
aminopeptidas
n
fapn
viral
receptor
fcov
enter
cell
endocytosi
attach
fapn
specul
low
endosom
ph
trigger
conform
chang
spike
protein
fcov
releas
viru
endosom
cytosol
howev
time
cytosol
entri
serotyp
unclear
fcov
infect
depend
intracellular
cholesterol
previou
studi
demonstr
triazol
antifung
agent
itraconazol
block
intracellular
traffick
cholesterol
inhibit
type
fcov
infect
felin
cell
line
feli
catu
whole
cell
cell
similar
result
observ
wide
studi
cholesterol
transport
inhibitor
research
report
itraconazol
block
cholesterol
egress
late
endosom
furthermor
cholesterol
accumul
report
disrupt
late
endosom
function
base
cholesterol
transport
inhibitor
hypothes
inhibit
releas
type
fcov
cytosol
indirectli
disrupt
late
endosom
function
howev
describ
site
endosom
releas
fcov
serotyp
investig
studi
demonstr
type
fcov
replic
cell
unless
reach
late
endosom
wherea
type
ii
fcov
even
though
reach
late
endosom
moreov
investig
effect
cholesterolaccumul
triazol
itraconazol
posaconazol
noncholesterolaccumul
triazol
voriconazol
fluconazol
infect
fcov
establish
felin
cell
line
feli
catu
whole
cell
cell
felin
primari
macrophag
cytotox
assay
perform
determin
nontox
concentr
compound
cell
figur
concentr
use
studi
select
low
cytotox
effect
cell
viabil
felin
cell
confirm
whether
fcov
access
late
endosom
cell
entri
investig
effect
nonspecif
late
endosom
traffick
inhibitor
fcov
assess
whether
inhibit
late
endosom
function
use
intracellular
cholesterol
accumul
index
affect
cholesterol
accumul
dosedepend
manner
figur
figur
suggest
type
fcov
enter
via
late
endosom
confirm
hypothesi
examin
effect
viral
infect
n
semicarbazon
ega
treatment
specif
inhibit
transport
earli
late
endosom
ega
significantli
suppress
fcovi
infect
fcovii
infect
figur
base
result
previou
studi
differ
fcov
serotyp
may
enter
felin
cell
differ
endocyt
rout
fcovi
releas
late
endosom
cytosol
wherea
fcovii
releas
earli
endosom
cytosol
cholesterol
accumul
previous
report
disrupt
late
endosom
function
therefor
investig
effect
cholesterolaccumul
triazol
itraconazol
posaconazol
noncholesterolaccumul
triazol
voriconazol
fluconazol
infect
fcov
next
investig
whether
find
similar
observ
cell
observ
macrophag
target
virul
fcov
fipv
concentr
triazol
antifung
disrupt
late
endosom
function
felin
primari
macrophag
confirm
ie
concentr
triazol
antifung
accumul
intracellular
cholesterol
measur
itraconazol
posaconazol
clearli
induc
cholesterol
accumul
figur
contrast
voriconazol
posaconazol
induc
cholesterol
accumul
even
concentr
limit
exhibit
cytotox
figur
examin
whether
fcov
replic
primari
macrophag
disrupt
late
endosom
function
experi
type
fcov
use
consider
limit
number
cat
addit
cytopath
effect
observ
viru
produc
cultur
supernat
type
fcovinfect
primari
macrophag
take
condit
consider
viral
infect
macrophag
judg
base
detect
fcov
n
protein
result
n
protein
level
fcovi
reduc
itraconazol
posaconazol
voriconazol
fluconazol
primari
macrophag
similar
cell
figur
virus
employ
sever
entri
strategi
endocytosi
viru
entri
occur
earli
late
endosom
accord
previou
studi
two
cell
entri
type
coronaviru
infect
cytosol
entri
earli
endosom
eg
merscov
infecti
bronchiti
viru
human
coronaviru
late
endosom
eg
sarscov
burkard
et
al
report
fcov
serotyp
unclear
enter
cytosol
late
endosom
demonstr
type
ii
fcov
enter
cytosol
late
earli
endosom
respect
figur
knowledg
virus
enter
cytosol
differ
time
among
serotyp
report
fcov
observ
studi
fcov
serotyp
distinguish
base
amino
acid
sequenc
protein
ie
time
serotyp
transit
cytosol
depend
protein
inde
cleavag
coronaviru
protein
endosom
play
import
role
cytosol
entri
cathepsin
l
endosom
proteas
involv
protein
cleavag
coronavirus
cholesterol
accumul
late
endosom
observ
cell
inhibit
cathepsin
l
activ
note
inhibit
cathepsin
l
activ
influenc
multipl
fcovii
investig
necessari
clarifi
whether
protein
cleavag
cathepsin
l
cholesterol
transport
influenc
cytosol
entri
fcov
oxysterol
produc
induc
interferon
although
inhibit
sever
viral
infect
mani
point
remain
unclear
regard
antivir
activ
civra
et
al
report
accumul
cholesterol
late
endosom
inhibit
rotaviru
infect
base
report
exhibit
antivir
activ
disrupt
late
endosom
function
confirm
inhibit
type
fcov
infect
cholesterolaccumul
concentr
ie
type
fcov
infect
block
mechan
rotaviru
infect
inhibit
base
find
appli
potent
antivir
agent
fcov
howev
oxysterol
induc
arteriosclerosi
therefor
investig
necessari
use
antivir
agent
fip
highconcentr
inhibit
type
ii
fcov
infect
reason
unclear
larg
amount
incorpor
endocytosi
may
physic
block
type
ii
fcov
releas
earli
endosom
fcov
serotyp
use
endosom
pathway
cell
entri
howev
time
cytosol
entri
serotyp
unclear
ega
prevent
transport
earli
endosom
late
endosom
type
ii
fcov
infect
inhibit
ega
demonstr
type
ii
fcov
enter
cytosol
reach
late
endosom
contrast
ega
inhibit
type
fcov
infect
thu
type
fcov
requir
late
endosom
enter
cytosol
tri
directli
demonstr
type
fcov
reach
late
endosom
ie
investig
coloc
late
endosom
marker
virion
unabl
find
commerci
antibodi
react
felin
necessari
produc
antibodi
react
felin
confirm
hypothesi
describ
base
previou
report
triazol
antifung
classifi
two
type
cholesterolaccumul
triazol
itraconazol
posaconazol
noncholesterolaccumul
triazol
voriconazol
fluconazol
knowledg
reason
differ
clarifi
differ
may
due
structur
drug
structur
itraconazol
similar
posaconazol
differ
voriconazol
fluconazol
trinh
et
al
report
itraconazol
posaconazol
bind
sterolsens
domain
sdd
niemannpick
diseas
type
induc
cholesterol
accumul
similarli
itraconazol
bind
sdd
unlik
drug
voriconazol
fluconazol
may
unabl
bind
sdd
hand
suggest
itraconazol
posaconazol
interfer
bind
type
fcov
addit
induc
cholesterol
accumul
bind
sdd
howev
cell
treat
sddbind
cholesterol
type
fcov
infect
increas
thu
inhibit
type
fcov
infect
drug
relat
bind
viru
sdd
fcovinfect
macrophag
play
import
role
develop
fip
previous
analyz
mechan
fcov
infect
felin
primari
macrophag
type
type
ii
fcov
incorpor
endocytosi
attach
cell
surfac
macrophag
unclear
fcov
enter
macrophag
degrad
consid
result
fcov
incorpor
macrophag
may
escap
degrad
macrophag
lysosom
escap
cytosol
earlyl
endosom
gener
infect
type
fcov
felin
cell
lower
type
ii
fcov
recent
obrien
et
al
establish
cell
cu
permit
type
fcov
replic
note
lower
interferon
sensit
factor
enabl
type
fcov
infect
cell
line
describ
inhibit
type
fcov
infect
induc
cell
interferon
suggest
induc
cu
even
though
interferon
produc
infect
hypothesi
correct
reason
increas
infect
type
fcov
cu
may
reduc
product
studi
indirectli
demonstr
type
fcov
enter
cytosol
unless
reach
late
endosom
wherea
type
ii
fcov
even
though
reach
late
endosom
find
warrant
studi
elucid
mechan
cell
entri
fcov
cell
kindli
suppli
dr
c
horzinek
utrecht
univers
grown
eagl
minimum
essenti
medium
mem
contain
medium
fetal
calf
serum
fc
uml
penicillin
ml
streptomycin
primari
macrophag
felin
primari
macrophag
select
felin
alveolar
macrophag
obtain
four
specificpathogenfre
spf
cat
age
year
bronchoalveolar
lavag
hank
balanc
salt
solut
felin
primari
macrophag
maintain
dmem
supplement
fc
uml
penicillin
streptomycin
spf
cat
maintain
temperaturecontrol
isol
facil
experi
use
anim
approv
presid
kitasato
univers
judgment
institut
anim
care
use
committe
kitasato
univers
perform
accord
guidelin
anim
experi
kitasato
univers
sampl
size
determin
base
previou
studi
minimum
number
cat
use
fcovi
isol
laboratori
fcovii
kindli
provid
dr
c
horzinek
utrecht
univers
virus
grown
cell
c
cholesterol
transport
inhibitor
ega
late
endosom
traffick
inhibitor
posaconazol
voriconazol
fluconazol
purchas
sigma
aldrich
japan
tokyo
japan
itraconazol
purchas
janssen
pharmacentr
k
k
tokyo
japan
dissolv
methanol
ega
posaconazol
voriconazol
fluconazol
dissolv
dimethyl
sulfoxid
dmso
itraconazol
dissolv
wv
hydroxypropylbetacyclodextrin
hbcd
solut
compound
adjust
mm
solvent
aliquot
store
c
use
day
experi
compound
dilut
desir
concentr
mainten
medium
cell
seed
plate
compound
ad
well
triplic
incub
defin
period
cultur
supernat
remov
solut
kishida
chemic
osaka
japan
ad
cell
return
incub
h
absorb
formazan
produc
measur
nm
use
spectrophotometr
plate
reader
describ
manufactur
percentag
viabil
calcul
use
follow
formula
cytotox
od
compounduntr
cell
od
compounduntr
cell
confluent
cell
monolay
cultur
medium
contain
compound
indic
concentr
multipl
c
h
cell
wash
viru
moi
adsorb
cell
c
h
wash
cell
cultur
carboxymethyl
cellulos
cmc
mem
cell
monolay
incub
c
h
fix
stain
crystal
violet
solut
contain
buffer
formalin
result
plaqu
count
plaqu
reduct
percentag
calcul
use
follow
formula
plaqu
reduct
percentag
plaqu
number
compoundtr
cell
plaqu
number
compounduntr
cell
felin
cell
cell
felin
primari
macrophag
cultur
well
labtek
chamber
slide
thermo
fisher
scientif
waltham
usa
semiconflu
cell
monolay
cultur
medium
contain
compound
c
h
cell
wash
viru
moi
adsorb
cell
c
h
h
case
macrophag
wash
cell
cultur
mem
cell
monolay
incub
c
h
n
protein
level
measur
immunofluoresc
assay
ifa
describ
previous
recogn
fcov
n
protein
mab
mous
prepar
laboratori
use
nuclei
stain
dapi
dojindo
laboratori
kumamoto
japan
cellular
cholesterol
content
cell
evalu
cholesterol
cellbas
detect
assay
kit
cayman
chemic
usa
accord
manufactur
instruct
briefli
cell
grown
labtek
chamber
slide
thermo
fisher
scientif
waltham
usa
semiconflu
cell
monolay
cultur
medium
contain
compound
c
h
fix
stain
filipin
iiibind
cell
analyz
use
leica
microscop
la
x
integr
imag
system
leica
microsystem
wetzlar
germani
data
two
group
analyz
student
ttest
welch
ttest
bartlett
test
data
multipl
group
analyz
oneway
anova
follow
tukey
test
